These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
262 related items for PubMed ID: 33176021
1. Detection of ERG11 Overexpression in Candida albicans isolates from environmental sources and clinical isolates treated with inhibitory and subinhibitory concentrations of fluconazole. Morais Vasconcelos Oliveira J, Conceição Oliver J, Latércia Tranches Dias A, Barbosa Padovan AC, Siqueira Caixeta E, Caixeta Franco Ariosa M. Mycoses; 2021 Feb; 64(2):220-227. PubMed ID: 33176021 [Abstract] [Full Text] [Related]
2. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms. Sanglard D, Coste AT. Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310 [Abstract] [Full Text] [Related]
3. Mutations and/or Overexpressions of ERG4 and ERG11 Genes in Clinical Azoles-Resistant Isolates of Candida albicans. Feng W, Yang J, Xi Z, Qiao Z, Lv Y, Wang Y, Ma Y, Wang Y, Cen W. Microb Drug Resist; 2017 Jul; 23(5):563-570. PubMed ID: 27976986 [Abstract] [Full Text] [Related]
4. Molecular mechanisms of drug resistance in clinical Candida species isolated from Tunisian hospitals. Eddouzi J, Parker JE, Vale-Silva LA, Coste A, Ischer F, Kelly S, Manai M, Sanglard D. Antimicrob Agents Chemother; 2013 Jul; 57(7):3182-93. PubMed ID: 23629718 [Abstract] [Full Text] [Related]
5. An A643T mutation in the transcription factor Upc2p causes constitutive ERG11 upregulation and increased fluconazole resistance in Candida albicans. Heilmann CJ, Schneider S, Barker KS, Rogers PD, Morschhäuser J. Antimicrob Agents Chemother; 2010 Jan; 54(1):353-9. PubMed ID: 19884367 [Abstract] [Full Text] [Related]
6. Rapid detection of ERG11 gene mutations in clinical Candida albicans isolates with reduced susceptibility to fluconazole by rolling circle amplification and DNA sequencing. Wang H, Kong F, Sorrell TC, Wang B, McNicholas P, Pantarat N, Ellis D, Xiao M, Widmer F, Chen SC. BMC Microbiol; 2009 Aug 14; 9():167. PubMed ID: 19682357 [Abstract] [Full Text] [Related]
7. ERG11 mutations and expression of resistance genes in fluconazole-resistant Candida albicans isolates. Xu Y, Sheng F, Zhao J, Chen L, Li C. Arch Microbiol; 2015 Nov 14; 197(9):1087-93. PubMed ID: 26349561 [Abstract] [Full Text] [Related]
11. Investigation of ERG11 gene expression among fluconazole-resistant Candida albicans: first report from an Iranian referral paediatric hospital. Teymuri M, Mamishi S, Pourakbari B, Mahmoudi S, Ashtiani MT, Sadeghi RH, Yadegari MH. Br J Biomed Sci; 2015 Nov 14; 72(1):28-31. PubMed ID: 25906488 [Abstract] [Full Text] [Related]
12. Correlation between azole susceptibilities, genotypes, and ERG11 mutations in Candida albicans isolates associated with vulvovaginal candidiasis in China. Ge SH, Wan Z, Li J, Xu J, Li RY, Bai FY. Antimicrob Agents Chemother; 2010 Aug 14; 54(8):3126-31. PubMed ID: 20516286 [Abstract] [Full Text] [Related]
13. Molecular mechanisms associated with Fluconazole resistance in clinical Candida albicans isolates from India. Mane A, Vidhate P, Kusro C, Waman V, Saxena V, Kulkarni-Kale U, Risbud A. Mycoses; 2016 Feb 14; 59(2):93-100. PubMed ID: 26648048 [Abstract] [Full Text] [Related]
14. UPC2A is required for high-level azole antifungal resistance in Candida glabrata. Whaley SG, Caudle KE, Vermitsky JP, Chadwick SG, Toner G, Barker KS, Gygax SE, Rogers PD. Antimicrob Agents Chemother; 2014 Aug 14; 58(8):4543-54. PubMed ID: 24867980 [Abstract] [Full Text] [Related]
15. Nucleotide substitutions in the Candida albicans ERG11 gene of azole-susceptible and azole-resistant clinical isolates. Strzelczyk JK, Slemp-Migiel A, Rother M, Gołąbek K, Wiczkowski A. Acta Biochim Pol; 2013 Aug 14; 60(4):547-52. PubMed ID: 24340302 [Abstract] [Full Text] [Related]
16. First detection of mutated ERG11 gene in vulvovaginal Candida albicans isolates at Ouagadougou/Burkina Faso. Dovo EE, Zohoncon TM, Tovo SF, Soubeiga ST, Kiendrebeogo IT, Yonli AT, Ouedraogo RA, Dabire AM, Djigma FW, Nadembega CW, Belemgnegre M, Ouedraogo P, Obiri-Yeboah D, Simpore J. BMC Infect Dis; 2022 Aug 08; 22(1):678. PubMed ID: 35941587 [Abstract] [Full Text] [Related]
17. Drug resistance genes and trailing growth in Candida albicans isolates. Lee MK, Williams LE, Warnock DW, Arthington-Skaggs BA. J Antimicrob Chemother; 2004 Feb 08; 53(2):217-24. PubMed ID: 14688046 [Abstract] [Full Text] [Related]
18. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Sanglard D, Kuchler K, Ischer F, Pagani JL, Monod M, Bille J. Antimicrob Agents Chemother; 1995 Nov 08; 39(11):2378-86. PubMed ID: 8585712 [Abstract] [Full Text] [Related]
19. A gain-of-function mutation in the transcription factor Upc2p causes upregulation of ergosterol biosynthesis genes and increased fluconazole resistance in a clinical Candida albicans isolate. Dunkel N, Liu TT, Barker KS, Homayouni R, Morschhäuser J, Rogers PD. Eukaryot Cell; 2008 Jul 08; 7(7):1180-90. PubMed ID: 18487346 [Abstract] [Full Text] [Related]
20. Gain-of-function mutations in UPC2 are a frequent cause of ERG11 upregulation in azole-resistant clinical isolates of Candida albicans. Flowers SA, Barker KS, Berkow EL, Toner G, Chadwick SG, Gygax SE, Morschhäuser J, Rogers PD. Eukaryot Cell; 2012 Oct 08; 11(10):1289-99. PubMed ID: 22923048 [Abstract] [Full Text] [Related] Page: [Next] [New Search]